These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 31199980

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.
    Purohit HS, Taylor LS.
    Pharm Res; 2017 Dec; 34(12):2842-2861. PubMed ID: 28956218
    [Abstract] [Full Text] [Related]

  • 4. Release Mechanisms of Amorphous Solid Dispersions: Role of Drug-Polymer Phase Separation and Morphology.
    Yang R, Zhang GGZ, Zemlyanov DY, Purohit HS, Taylor LS.
    J Pharm Sci; 2023 Jan; 112(1):304-317. PubMed ID: 36306863
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
    Sun DD, Ju TC, Lee PI.
    Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers.
    Sun DD, Lee PI.
    J Control Release; 2015 Aug 10; 211():85-93. PubMed ID: 26054795
    [Abstract] [Full Text] [Related]

  • 11. Molecular structure and impact of amorphization strategies on intrinsic dissolution of spray dried indomethacin.
    Li Y, Rantanen J, Yang M, Bohr A.
    Eur J Pharm Sci; 2019 Mar 01; 129():1-9. PubMed ID: 30553059
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Drug Release from Surfactant-Containing Amorphous Solid Dispersions: Mechanism and Role of Surfactant in Release Enhancement.
    Yang R, Zhang GGZ, Zemlyanov DY, Purohit HS, Taylor LS.
    Pharm Res; 2023 Dec 01; 40(12):2817-2845. PubMed ID: 37052841
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dissolution Mechanisms of Amorphous Solid Dispersions: A Close Look at the Dissolution Interface.
    Deac A, Qi Q, Indulkar AS, Gao Y, Zhang GGZ, Taylor LS.
    Mol Pharm; 2023 Apr 03; 20(4):2217-2234. PubMed ID: 36926898
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction.
    Chen Y, Wang S, Wang S, Liu C, Su C, Hageman M, Hussain M, Haskell R, Stefanski K, Qian F.
    Pharm Res; 2016 Oct 03; 33(10):2445-58. PubMed ID: 27283830
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Role of Surfactants on Release Performance of Amorphous Solid Dispersions of Ritonavir and Copovidone.
    Indulkar AS, Lou X, Zhang GGZ, Taylor LS.
    Pharm Res; 2022 Feb 03; 39(2):381-397. PubMed ID: 35169959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.